Brown algal bioactive molecules: a new frontier in oral cancer treatment

Kuppusamy Sathishkumar1, Malairaj Sathuvan1

  • 1Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

PubMed

Insights

Brown algae compounds show promise for treating oral squamous cell carcinoma (OSCC). Research highlights their potential to inhibit cancer growth and induce cell death, offering new therapeutic avenues.

Area of Science:

  • Marine Biotechnology
  • Oncology
  • Natural Product Chemistry

Background:

  • Oral Squamous Cell Carcinoma (OSCC) is an aggressive cancer requiring novel therapeutic strategies.
  • Brown algae possess diverse bioactive compounds with demonstrated anticancer properties.

Purpose of the Study:

  • To investigate the potential of brown algae-derived compounds as therapeutic agents against OSCC.
  • To explore the mechanisms of action of these compounds in inhibiting OSCC progression.

Main Methods:

  • Analysis of bioactive compounds in brown algae, including polyphenols, carotenoids, and polysaccharides.
  • In vitro and in vivo studies evaluating the anti-OSCC effects of compounds like fucoxanthin and fucoidan.
  • Investigation of nanoparticle formulations (e.g., celecoxib-loaded chitosan-fucoidan) for enhanced delivery and efficacy.

Main Results:

  • Brown algae compounds effectively inhibit OSCC cell proliferation and induce apoptosis.
  • Key compounds such as fucoxanthin and fucoidan target specific cancer pathways.
  • Nanoparticle formulations show potential for multi-pathway OSCC treatment.

Conclusions:

  • Brown algae represent a valuable source for developing novel anti-OSCC therapies.
  • Further preclinical and clinical research is necessary to translate these findings into effective treatments.
  • Marine-derived natural products offer a promising frontier in oral cancer therapeutics.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K